Translational research is the bridge between laboratory science and clinical practice, enabling the rapid application of discoveries from the bench to the bedside. It involves converting insights from cancer biology, genetics, and molecular pathways into new diagnostic tools, treatment strategies, and prevention methods that can be tested in clinical trials. Translational research is focused on improving clinical trial design, identifying biomarkers that predict treatment responses, and enhancing patient recruitment strategies to ensure diverse representation in studies. By refining these aspects, translational research accelerates the process of developing innovative, evidence-based treatments that can significantly improve patient outcomes. This approach emphasizes collaboration between researchers, clinicians, and the healthcare system to bring cutting-edge science directly to those in need, driving meaningful improvements in cancer care.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States